涨超5%,司美格鲁肽片剂上市首日开出3071张处方

华创新药
Jan 17

诺和诺德周五发布消息称,该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。据巴克莱分析师的报告,实际的处方数量将会更高,因为这些数据只包含了这种每日服用一次的口服GLP-1激动剂的零售处方,不包括通过诺和诺德直营平台诺和药房提交的处方。该公司于1月5日以每月149美元的价格向现金支付的客户推出了这款产品,随后,亚马逊等零售商也加入了推广队伍。去年12月美国批准了...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10